Parathyromatosis Following Endoscopic Parathyroid Surgery: A Rare Occurrence
Sir, Parathyromatosis, a cause for recurrent hyperparathyroidism is common in middle-aged women and chronic kidney disease patients. It involves multiple nodules of benign hyperfunctioning parathyroid tissue scattered throughout the neck and mediastinum. [1, 2] Primary or Type 1 parathyromatosis is the result of hyperplasia of parathyroid rests from embryologic development. [3] Secondary or Type 2 parathyromatosis, a rare complication of parathyroidectomy, first described in 1975 by Palmer et al., [4] is more common which arises due to seeding of parathyroid tissue during surgery. It has been also considered as a low-grade malignancy. [5] Thirty-five cases have been reported so far. [6] Its preoperative diagnosis is rare due to the lack of awareness of this entity. Sonographic imaging provides clues to the diagnosis. [7] Medical and surgical interventions carry high failure rates. Cinacalcet and bisphosphonates are main-stays of medical therapy. Alcohol ablation and several novel calcimimetics have been used in these patients. [8] Repeated neck explorations to remove parathyroid implants are often unsuccessful.
We came across a 55-year-old male with bone pains, pruritus, polyuria, difficulty in getting up from the chair for the last 1 year. He was operated in the past for renal stones. He was diagnosed with primary hyperparathyroidism (PHPT) due to left superior parathyroid adenoma and got operated endoscopically for the same. Postsurgery, discharged medications included oral calcium and Vitamin D supplements. Two years after the surgery, he presented with bone pains and increasing fatigue. Physical examination was unremarkable. Serum calcium was 14 mg/dl, intact parathyroid hormone (PTH) was 1400 pg/ml, and 24-h urinary calcium was 649.28 mg/dl, suggestive of recurrent hyperparathyroidism. Ultrasonography, sestamibi and positron emission tomography scans failed to localize lesion. Differential diagnosis of incomplete removal of adenoma, hyperplasia, multiple/ectopic adenoma, malignancy, and parathyromatosis were considered. On exploration [ Figure 1a ], multiple nodules (<5 mm) were evident in the left-side neck Parathyromatosis is a rare but clinically relevant disease. It is characterized by ectopic hormone secreting parathyroid tissue scattered throughout the neck and mediastinum. It may be considered a benign malignancy with locally invasive behavior. In our opinion, the cause of secondary hyperparathyroidism, in this case, was most likely due to rupture of capsule leading to spillage of tumor cells during removal of parathyroid adenoma by endoscopic parathyroid surgery. Secondary parathyromatosis following endoscopic parathyroid surgery has not been reported so far. The preoperative diagnosis of parathyromatosis poses great challenges and needle aspiration may be helpful in selected patients. [9] The sonographic appearance of parathyromatosis may mimic that of disseminated local malignancy. [7] Parathyroid carcinoma is an important differential diagnosis, but significantly elevated serum calcium (>14 mg/dl) are seen in carcinoma. [1] Histopathology can be diagnostic.
The surgery to control parathyromatosis is often unsuccessful. To identify and remove all the parathyroid nodules is extremely difficult. Regular follow-ups are necessary to diagnose any recurrence. Medical treatment with calcimimetics such as cinacalcet and bisphosphonate may be considered in those with failed surgery or unfit for surgery. To the best of our knowledge, this is the first observation of parathyromatosis following an endoscopic surgery removal of benign parathyroid adenoma which calls for vigilant follow up in such cases.
Sir, Type 1 diabetes mellitus (T1DM) is one of the important public health problems worldwide. In developed countries, the incidence rate of pediatric T1DM continues to rise by an average of approximately 3%-4% per annum, but the increase is not necessarily uniform, showing periods of less rapid and more rapid increase in incidence in some registers. [1] Over the past several decades, a global rise in the prevalence of T1DM in the pediatric population has been noted. The alarming increase in the prevalence is predicted to occur due to multiple genetic and environmental risk factors. [2] The economic burden for children with T1DM is substantial. [3] In Iraq, no recent data are yet present on the exact prevalence of pediatric T1DM. However, the available data on the pediatric TIDM estimates in 2010 pointed out to the 2.8/1000 prevalence. [4] In Iraq, children with newly diagnosed T1DM are included into the database of health-care system. They are treated and followed up at the level of primary health-care centers (PHCs). Through the ration system employed in Iraq since 1990, they are provided with drug dispensing cards (DDCs) and monthly offered their required need of insulin therapy and injection equipment (e.g., needles and syringes, insulin pens).
Optimum care of diabetic children in Iraq currently faces challenges in the aspects of treatment and follow-up. After decades of war, sanctions, occupation, administrative corruption, and poor governance, the health-care system in Iraq is eroded and under-resourced. [5] This along with organization mismanagement makes it fruitless. It is based on the PHCs and majority of diabetic patients are treated and followed up at this level, referring the complicated cases to secondary or tertiary hospital care or specialized diabetes centers (SDCs). Most of the time, the provision of insulin and injection equipment by DDCs is irregular, and it is not prescribed according to the patient's need. Glucose strips for home testing are not provided free by
